Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease

NCT00434278 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00434278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00434278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease
Lead sponsor
Genentech, Inc.
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2007
Completion date
November 30, 2008
Enrollment
27 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis